Blog - Page 3624 of 5500

ThursdayJun 03, 2010 8:27 am

Vanguard Minerals, Inc. (VNGM.OB) Launches New Operating Division GreenZone Ventures

Vanguard Minerals, Inc., a strategic management consulting and business development firm with core competency in emerging growth companies, recently announced that it has launched GreenZone Ventures, a new venture capital and incubation division. With a primary goal of identifying, investing in, partnering with and supporting companies in the “green energy” industry, GreenZone will target bio-fuels and emerging technology companies in the start up through third round phases of business. Woody Junot will head the new division and provide consulting services by the start of the third quarter of 2010. “We are forming this division to address a significant void in…

ThursdayJun 03, 2010 8:26 am

China Wi-Max Communications, Inc. (CHWM.OB) Enters into Strategic Agreement with CJ Network Consultation and Services Company

China Wi-Max Communications, Inc. has enhanced operations and potential customers in Beijing significantly via a strategic agreement with Beijing's CJ Network Consultation and Services Company. CJ Network operates as a fiber based access provider in Beijing, People's Republic of China. They are a licensed ISP, and they provide Internet access mainly to buildings in Beijing's "Silicon Valley" area following the 3rd Ring Road. CJ Network will engineer and construct fibers from China Wi-Max Communications, Inc.'s 4th Ring Road fiber backbone for up to nine new business buildings. CJ Network will maintain fiber and in-building access to customers, in addition to…

ThursdayJun 03, 2010 8:17 am

N-Viro International Corp. (NVIC.OB) Announces Five-Year Extension on Altamonte Springs Contract

Yesterday, environmental technology company N-Viro International Corporation announced that it has extended its agreement with the City of Altamonte Springs, Florida for an additional five years. The contract extension represents approximately $1.8 million of revenue over the next five years. A long-term N-Viro customer, Altamonte Springs has been working with the company’s wholly owned subsidiary, Florida N-Viro, for over 10 years. Altamonte Springs represents about 10% of the revenue brought in from Volusia County, and this extension ensures that Florida N-Viro will continue to process all of Altamonte Springs' biosolids into a Class AA beneficial reuse product. CEO and President…

ThursdayJun 03, 2010 7:45 am

Cellceutix Corp. (CTIX.OB) CFO Partakes in Exclusive Interview to Discuss Autism Drug, Kevetrin(TM) and Various Progressions

Cellceutix Corp. was pleased to announce that its Chief Financial Officer, Leo Ehrlich, has been featured in an interview with leading online financial publication, CEOCFO Interviews and News. Conducted by CEOCFO Senior Editor Lynn Fosse, the interview highlighted the distinctiveness of Cellceutix and the reasons why the company stands out from all other biotech companies in the industry. Mr. Ehrlich discussed the progressions of KM-391, Cellceutix's compound for the treatment of autism, and Kevetrin, which is being developed as a treatment for drug-resistant cancers. He also explained why their autism drug is revolutionary as there is no drug currently available…

WednesdayJun 02, 2010 3:57 pm

ImmunoCellular Therapeutics Ltd. (IMUC) to Present Cancer Vaccine Candidate

ImmunoCellular Therapeutics Ltd. is a biotechnology company focused on the development of novel immune-based cancer therapies. Data from the company’s recent clinical trial of ICT-107, the company's dendritic cell-based cancer vaccine candidate, will be presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) June 4-8 in Chicago. "Immune response correlation with progression-free survival in glioblastoma (GBM) following dendritic cell immunotherapy (ICT-107)" will feature data showing ICT-107’s efficiency in significantly increasing survival rates in patients who received the vaccine. The company’s phase I clinical included the study of ICT-107 in newly diagnosed patients who received the…

WednesdayJun 02, 2010 3:55 pm

Biomoda Inc. (BMOD.OB) Inks Deal with Obio to Support Cancer Detection Research and Development

Cancer diagnostics company Biomoda Inc. today announced it has signed an agreement with Obio, a corporation formed to pursue public and private funding for cancer research, to establish a CLIA-certified Biomoda clinical laboratory in Ohio to fuel ongoing research and development of Biomoda's porphyrin-based assay for the detection of early-stage cancer. Clinical Laboratory Improvement Amendments (CLIA) were implemented by Congress in 1988 and certified by the Department of Health and Human Services to set boundaries and regulations for laboratory testing to ensure accuracy and reliability of patient test results. For Biomoda, the agreement will strengthen its partnership with Obio and…

WednesdayJun 02, 2010 3:34 pm

Skinny Nutritional Corp. (SKNY.OB) Dramatically Expands Mid-Atlantic Distribution through Turkey Hill Minit Markets Agreement

Skinny Nutritional Corp. announced today that they have signed an agreement to now have Skinny Water available at more than 250 Turkey Hill Minit Markets locations throughout the Mid-Atlantic and Midwest. Operating for more than 40 years, Turkey Hill, one of five convenience store divisions in the United States operated by The Kroger Co (NYSE: KR), currently has over 250 stores in Pennsylvania, seven stores in the Columbus, Ohio area, and one store in Martinsville, Indiana. Most of the Turkey Hill Minit Markets are full-service retailers offering 24-hour service and a large selection of snacks and beverages as well as…

WednesdayJun 02, 2010 2:31 pm

Cellceutix Corp. (CTIX.OB) is “One to Watch”

Cellceutix Corp., an emerging bio-pharmaceutical company, is in the early stages of receiving an influx of media attention and widespread notoriety within the pharmaceutical industry due to the promising results shown during the early development of a compound for the treatment of autism, KM-391, and the approaching Phase 1 clinical trials of Kevetrin™, the company's compound for the treatment of drug-resistant cancers. In addition to these two, Cellceutix currently manages a portfolio of six other promising compounds. KM-391, a 100% novel compound, is revolutionary in that it addresses the core issues of autism, unlike the pharmaceuticals presently on the market…

WednesdayJun 02, 2010 12:14 pm

Sillenger Exploration Corp. (SLGX.OB) Secures Massive Mineral and Hydrocarbon Exploration and Survey Contract with Equatorial Guinea’s Government

Sillenger Exploration Corp., www.sillenger.com, is a mineral exploration and claims management firm driven by an evolved business model which is squarely focused on growing shareholder equity through acquisition and development of opportunities with strong fundamentals (primarily targeting the rich reserves of Africa at this time). The Company announced today that it has entered into a contract with the Government of the Republic of Equatorial Guinea to conduct a massive aerial survey project . Via Sillenger’s strong ties with its affiliates in Africa and at FCMI Global Inc., SLGX has secured the exploration mining concessions, including oil and gas, revealed by…

WednesdayJun 02, 2010 12:11 pm

Beacon Enterprise Solutions Group, Inc. (BEAC.OB) Retains Mark Gervasoni as Chief Marketing & Sales Officer

Beacon Enterprise Solutions Group, Inc., www.askbeacon.com – a titan forged from the union of four independently successful IT/telecom firms, is a fully integrated leader in the sector with a proven track record of designing and successfully implementing comprehensive Information Technology System (ITS) architectures. The Company disclosed details today regarding the appointment of Mark Gervasoni to Chief Marketing & Sales Officer. Gervasoni brings a wide range of industry experience to the position, along with a strong portfolio of former activity: • 51 years old with 15 years in sales/management for public sector and private sector Fortune 1000 companies • Sales Director…

Site Search

Company Search